Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

CD90-targeted lentiviral vectors for HSC gene therapy

Molecular Therapy(2023)10.1016/j.ymthe.2023.08.003Source: DataRank Database

CD90-targeted lentiviral vectors for HSC gene therapy is a research paper published in Molecular Therapy (2023). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

Linked data & code

pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 4.70)OA: bronzeTopics (37)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Justin Thomas,Eman A. Taha ORCID,Seunga Choo ORCID,Ravishankar Madhu ORCID,Greta Kanestrom

Live enrichment

PubMed:37550965 PMC:PMC10556220 OpenAlex:https://openalex.org/W4385633813

National Heart Lung and Blood Institute

Grant: R01 HL136135

National Institute of Allergy and Infectious Diseases

Grant: R01 AI135953–01

NIAID NIH HHS

Grant: R01 AI135953

NIAMS NIH HHS

Grant: T32 AR069516

National Institutes of Health

FWCI

4.70

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

bronzeLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/

journalhttp://www.cell.com/article/S1525001623004355/pdf

publisherhttp://www.cell.com/article/S1525001623004355/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1525001623004355?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1525001623004355?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ymthe.2023.08.003

Fields of Study

Virus-based gene therapy researchRNA Interference and Gene DeliveryViral Infectious Diseases and Gene Expression in InsectsHumansAntigens, CD34Genetic TherapyGenetic VectorsHematopoietic Stem Cell TransplantationHematopoietic Stem Cells

MeSH Terms

Genetic VectorsHematopoietic Stem CellsHumansGenetic TherapyHematopoietic Stem Cell TransplantationAntigens, CD34

Keywords

CD90Genetic enhancementHematopoietic stem cellStem cellCD34HaematopoiesisGeneBiologyViral vectorCancer researchVirologyGeneticsRecombinant DNAGene therapyHematopoietic stem cellsHSCsscfvMeaslesVsvgSingle Chain Variable FragmentsHsc TargetingSurface-engineered Viral Vectors

Sustainable Development Goals

SDG 0: Industry, innovation and infrastructure

CD90-targeted lentiviral vectors for HSC gene therapy

FAIR Checklist

Authors (10)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)